UK markets open in 3 hours 14 minutes

Ipsen S.A. (IPSEF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
132.50+14.90 (+12.67%)
At close: 11:28AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close117.60
Open132.50
Bid0.00 x 0
Ask0.00 x 0
Day's range132.50 - 132.50
52-week range108.75 - 132.50
Volume171
Avg. volume45
Market cap10.958B
Beta (5Y monthly)0.63
PE ratio (TTM)14.59
EPS (TTM)9.08
Earnings date25 Jul 2024
Forward dividend & yield1.28 (1.08%)
Ex-dividend date30 May 2024
1y target estN/A
  • Globe Newswire

    Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting

    Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting BOULOGNE-BILLANCOURT, FRANCE, 7 May 2024 - The Shareholders of the Company are invited to participate in the Combined Shareholders’ Meeting of Ipsen (Euronext: IPN; ADR: IPSEY) to be held on Tuesday 28 May 2024 at 3:00 p.m. (Paris time) at the Salons de l'Hôtel des Arts et Métiers, 9 bis avenue d'Iéna, 75116 Pa

  • Globe Newswire

    Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

    Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting rights (1) 30 April 2024 83,814,526 Gross total* of voting rights: 132,102,659 Net total*

  • GlobeNewswire

    Ipsen appoints Keira Driansky as EVP, President of North America

    PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the Executive Leadership Team (ELT) and report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “We are thrilled to welcome Keira to Ipsen as our new President of North America as she brings extensive experience in the life sciences industry